ArticleAnnals of translational medicine2018

Targeting properdin in the treatment of atypical haemolytic uraemic syndrome: better than eculizumab?

Kate Smith-Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.